Search research articles
Contact Us
Filters
Showing results (571-580 of 722) with videos related to
Page
of 73
Sort By:
Nature Communications
|
July 30, 2025
Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence
Alexander O Pasternak, Pien M van Paassen, Yara L Verschoor, et al.
Plos One
|
November 19, 2019
Implementation and evaluation of an antimicrobial stewardship programme in companion animal clinics: A stepped-wedge design intervention study
Nonke E M Hopman, Lützen Portengen, Marlies E J L Hulscher, et al.
Annals of Internal Medicine
|
February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infection
A M de Roda Husman, M Koot, M Cornelissen, et al.
Cancer Research
|
February 28, 2001
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
J S Yu, C J Wheeler, P M Zeltzer, et al.
AIDS Research and Human Retroviruses
|
February 1, 2007
Antiviral activity of HIV type 1 protease inhibitors nelfinavir and indinavir in vivo is not influenced by P-glycoprotein activity on CD4+ T cells
Sanjay U C Sankatsing, Marion Cornelissen, Nico Kloosterboer, et al.
Trials
|
April 23, 2014
Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial
Willeke F Westendorp, Jan-Dirk Vermeij, Nan van Geloven, et al.
Archives of Internal Medicine
|
July 12, 2012
Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women
Mariëlle A J Beerepoot, Gerben ter Riet, Sita Nys, et al.
Nature Communications
|
May 8, 2024
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial
Richard G Everson, Willy Hugo, Lu Sun, et al.
Viral Immunology
|
December 15, 2010
Immunological analysis of treatment interruption after early highly active antiretroviral therapy
Ingrid M M Schellens, Katalin Pogany, Geertje H A Westerlaken, et al.
European Radiology Experimental
|
July 18, 2020
Classifying the diagnosis of study participants in clinical trials: a structured and efficient approach
Tjitske S R van Engelen, Maadrika M N P Kanglie, Inge A H van den Berk, et al.
Page
of 73
Search research articles
Search
Showing results (571-580 of 722) with videos related to
Sort By:
Page
of 73
Nature Communications
|
July 30, 2025
Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence
Alexander O Pasternak, Pien M van Paassen, Yara L Verschoor, et al.
Plos One
|
November 19, 2019
Implementation and evaluation of an antimicrobial stewardship programme in companion animal clinics: A stepped-wedge design intervention study
Nonke E M Hopman, Lützen Portengen, Marlies E J L Hulscher, et al.
Annals of Internal Medicine
|
February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infection
A M de Roda Husman, M Koot, M Cornelissen, et al.
Cancer Research
|
February 28, 2001
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
J S Yu, C J Wheeler, P M Zeltzer, et al.
AIDS Research and Human Retroviruses
|
February 1, 2007
Antiviral activity of HIV type 1 protease inhibitors nelfinavir and indinavir in vivo is not influenced by P-glycoprotein activity on CD4+ T cells
Sanjay U C Sankatsing, Marion Cornelissen, Nico Kloosterboer, et al.
Trials
|
April 23, 2014
Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial
Willeke F Westendorp, Jan-Dirk Vermeij, Nan van Geloven, et al.
Archives of Internal Medicine
|
July 12, 2012
Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women
Mariëlle A J Beerepoot, Gerben ter Riet, Sita Nys, et al.
Nature Communications
|
May 8, 2024
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial
Richard G Everson, Willy Hugo, Lu Sun, et al.
Viral Immunology
|
December 15, 2010
Immunological analysis of treatment interruption after early highly active antiretroviral therapy
Ingrid M M Schellens, Katalin Pogany, Geertje H A Westerlaken, et al.
European Radiology Experimental
|
July 18, 2020
Classifying the diagnosis of study participants in clinical trials: a structured and efficient approach
Tjitske S R van Engelen, Maadrika M N P Kanglie, Inge A H van den Berk, et al.
Page
of 73